5.2 Radiopharmaceutical Kit Preparation
Key Takeaways
- Cold kits contain nonradioactive ligands and a reducing agent (usually stannous ion); Tc-99m pertechnetate is added to form the labeled radiopharmaceutical
- Strict activity and volume limits on the package insert protect labeling efficiency, purity, and (for MAA) particle number
- Patient dose calculations use assayed kit concentration, decay correction, and ordered activity—never guess volume without math
- MAA particle size is typically in the 10–90 μm range; adult doses use a controlled particle count, reduced for children and pulmonary hypertension
- Store unreconstituted kits per labeled temperature; after reconstitution, observe manufacturer expiration (often hours), temperature, and light protection
A cold kit is a sterile, nonradioactive vial with ligand, usually a reducing agent, and stabilizers. Adding Tc-99m sodium pertechnetate creates the radiopharmaceutical. Domain III expects correct reconstitution, activity/volume limits, patient-dose math, and special rules for MAA.
Cold Kit Reconstitution Workflow
Always follow the package insert:
- Verify kit ID, lot, unreconstituted expiration, and storage history.
- Assay Tc-99m pertechnetate; confirm Mo-99 and Al³⁺ QC are acceptable.
- Aseptically add the correct activity in the correct volume (some kits need diluent or a specific order of addition).
- Mix as directed; complete any required incubation or heating (e.g., certain MAG3, sestamibi, or sulfur colloid protocols).
- Assay the vial, calculate concentration, and label name, activity, concentration, time, expiration, and lot.
- Draw patient doses with a syringe shield, assay each syringe, and document.
Use aseptic technique: sterile needles, swabbed septa, no-touch method, and laminar-flow or equivalent controls when policy/USP <825> practices apply.
Labeling Chemistry (Reduction of Pertechnetate)
Eluate contains pertechnetate, Tc(VII)—chemically unreactive toward most ligands. Kits include stannous ion (Sn²⁺) that reduces technetium so it can complex MDP, DTPA, MIBI, tetrofosmin, mebrofenin, and similar ligands.
| Concept | Meaning |
|---|---|
| TcO₄⁻ | Oxidized Tc(VII); “free tech” if unbound |
| Stannous reduction | Sn²⁺ lowers Tc oxidation state for ligand binding |
| Air / oxidants | Reoxidation → free pertechnetate |
| Too much Tc or weak Sn²⁺ | Incomplete labeling |
| HR-Tc | Reduced Tc forming colloid instead of the intended complex |
Stay inside insert limits; avoid oxidants and unnecessary air; do not use high-Al³⁺ eluate when warned. Some products use ligand exchange, boiling, or pH control—the core idea remains reduce, then bind.
Activity and Volume Limits
Inserts set max/min Tc-99m activity and reconstitution volume:
- Too much activity can overwhelm reducing capacity → poor RCP.
- Wrong volume changes concentration and dose logistics.
- Insufficient Sn²⁺ relative to Tc → free tech or colloids.
Limits apply at preparation; multi-dose use must stay within post-reconstitution shelf life.
Worked example 1 — Kit limits
Insert: 20–100 mCi in 1–5 mL. Need five ~20 mCi doses → 100 mCi in 5 mL (20 mCi/mL) is within limits. Loading 150 mCi “to save a vial” violates the insert and risks failed QC.
Patient Dose Calculations
[ \text{Concentration (mCi/mL)} = \frac{\text{Total activity}}{\text{Total volume}} ] [ V = \frac{\text{Ordered activity}}{\text{Concentration}} ]
Decay if injection is delayed (Tc-99m (T_{1/2} ≈ 6\ \text{h})):
[ A_t = A_0 \left(\frac{1}{2}\right)^{t/T_{1/2}} ]
Worked example 2 — Draw volume
80 mCi in 4 mL → 20 mCi/mL. Order 25 mCi → 1.25 mL. Assay the syringe and adjust if needed.
Worked example 3 — Decay
Syringe 25 mCi at 08:00; inject at 11:00 (3 h):
[ A = 25 \times (1/2)^{3/6} = 25 \times \sqrt{1/2} ≈ 25 \times 0.707 ≈ \mathbf{17.7\ mCi} ]
If 25 mCi is required at injection, draw more at 08:00 or redraw later.
Worked example 4 — Units
Order 740 MBq MDP → 740/37 = 20 mCi for calibrator math; document in the unit your facility requires.
MAA: Particle Size and Number
Tc-99m MAA is particulate; aggregates temporarily lodge in pulmonary arterioles/capillaries.
| Parameter | Teaching range | Why |
|---|---|---|
| Particle size | Roughly 10–90 μm | Too small → pass lungs; too large → larger-vessel obstruction |
| Adult particle number | Often ~200,000–700,000/dose (follow insert) | Uniform map without excess blockade |
| Pediatrics | Reduce particles (and often activity) | Smaller vascular bed |
| Pulmonary hypertension / R-to-L shunt protocols | Reduce particles | Limit occlusion / systemic particle risk |
Do not inject blood into the MAA vial (clumping); gently resuspend before drawing; never use a 0.22 μm filter that strips particles; reject clumped product. High activity in small volume raises particles per mL—count matters as much as mCi.
Worked example 5 — Particles
Vial: 6 × 10⁶ particles in 6 mL, 30 mCi → 1 × 10⁶ particles/mL and 5 mCi/mL. A 4 mCi adult draw (0.8 mL) ≈ 800,000 particles—may exceed lab ceilings; dilute or prepare lower particle density. Child limited to 100,000 particles → 0.1 mL of that suspension (activity only 0.5 mCi unless a low-density prep is used).
Storage and Expiration
| State | Controls |
|---|---|
| Unreconstituted kit | Labeled fridge or room temp; light protection if stated; freeze only if allowed |
| After reconstitution | Temp per insert; multi-dose aseptic withdrawals |
| Expiration | Unreconstituted manufacturer dating; post-reconstitution often ~6–12 h (product-specific) |
| Eluate age | Some kits prefer fresh eluate |
Reject expired kits, failed visual/RCP products, and temperature-abused vials per RSO/pharmacy policy.
Multi-Dose Logistics
Plan kit activity so morning and afternoon lists fit inside both the activity limit and the expiration clock. If the last dose would be drawn after dating, prepare a second kit rather than stretching a marginal vial. Always assay the patient syringe, not only the bulk vial, before administration.
Exam hooks: Sn²⁺ reduces TcO₄⁻; honor activity/volume limits; mCi/mL + decay math; MAA particle number (peds/PHTN); storage/expiration differ before vs after reconstitution.
Why do most Tc-99m cold kits contain stannous (Sn²⁺) ion?
A reconstituted kit contains 60 mCi in 3 mL at assay time. What volume is needed for a 20 mCi patient dose if injection is immediate?
For Tc-99m MAA lung perfusion imaging, which practice is most appropriate?